Mentamove® therapy is based on the principles of Neuroplasticity and Mental Practice of motor skills. It is an EMG initiated Neuromuscular Electrical Stimulator (brain efficiency training) with the approach that starts with the point of the illness, the central nervous system.
The success rate of Mentamove® is 80 to 90%.
Mentamove® therapy has the patient imagine a movement or scenario, this then generates an impulse within the brain that is the basis for the execution of this movement.
The Mentamove® measures the impulses still arriving at the muscle. Once a set marginal value is reached, the Mentamove® device switches over to stimulation.
The muscle will executes this imagined movement; the execution of the movement is reported back to the brain and stored there.
The learning process has therefore been carried out within the brain. The Mentamove® therapy has successfully treatment over 25,000 patients around the world and that number is growing everyday.
With the Mentamove® the desired learning process is promoted considerably better than in the case of conventional therapy forms with generally only the muscle being stimulated without any learning process in the brain.
Ask your doctor today about the clinical results EMG initiated NES rehabilitation therapy has been able to provide to Stroke patients.
For more information:
